Clinical Trial

Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)

Name: Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU) — clinical trial record (NCT06569602)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This is a prospective, single-arm, multi-center, real-world study of an the Edwards EVOQUE system.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-08-21.

Status change: Not Yet Recruiting → Recruiting 2024-10-29

Trial Details

NCT Number	NCT06569602
Lead Sponsor	Edwards Lifesciences
Conditions	Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases
Enrollment	500 participants
Start Date	2024-10-01
Primary Completion	2030-09-30 (estimated)
Study Completion	2033-09-30 (estimated)
Updated on ClinicalTrials.gov	2024-10-31